Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

16 Dec 2013 07:00

RNS Number : 5455V
Impellam Group plc
16 December 2013
 



 

 

Impellam Group plc ("Impellam" or the "Company" or "Group")

 

Pre close trading statement

 

Impellam is pleased to announce that trading during the second half of the year reflects the improving economic conditions in the Group's key markets. Our staffing businesses are all expected to see year over year growth in net fees in the second half of the year with both our UK Staffing and US Staffing business seeing full year on year growth.

 

The Group is planning to capitalise on the opportunities available in both the managed services and specialist staffing markets. Both the UK and the US Staffing businesses are keen to accelerate investment in headcount which will lead to upward cost pressure.

 

Whilst we anticipate year on year growth in operating profits in both our UK and US Staffing businesses, the costs associated with both enhanced compliance requirements and the sourcing of medical professionals is still depressing net fee conversion in our Medacs business. Accordingly, Medacs will report year on year operating profit contraction in the second half, albeit at a slower rate than we saw in the first half.

 

The Group's staffing businesses, in total, are therefore expected to see a small year on year decrease in operating profits. However, the outlook is promising with increased activity and recovering markets.

 

Trading in our Carlisle Support Services business has shown some early signs of improvement. Changes to the management structure announced at the half year are starting to deliver the benefits we anticipated in the mobilisation of high volume labour solutions to the retail, transport and logistics sectors. Whilst second half trading will not show any material improvement due to restructure costs, the outlook is more favourable. However, the business has two long term contracts, one a substantial first generation out sourcing agreement, which have proven to be operationally complex, badly priced and financially onerous. In accordance with accounting standards, full provision will be made for the costs of the exiting of one and the future ongoing losses of the other. The total provision, amounting to some £13.0 million, will be taken as an exceptional item. Having carefully reviewed the contracts portfolio, we are satisfied that no other similar contracts exist in the Group.

 

Total Group adjusted operating profit is expected to be about £5.0 million lower than the comparative period last year.

 

During the year, Impellam has returned £19.8 million to shareholders in dividends. The return of cash to shareholders remains a key objective for the Group. A final dividend of 7.0p per share will be recommended. Further details of this will be announced in due course.

 

Enquiries: For further information please contact the appropriate individual below.

 

 

Impellam Group plc

Andrew Wilson

Julia Robertson

Andrew Burchall Tel: 01582 692658

 

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

Elizabeth Bowman

 

 

Note to Editors:

 

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,500 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 17th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEXLFFXLFXFBF
Date   Source Headline
22nd Nov 202311:40 amRNSForm 8.5 (EPT/RI)
22nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
21st Nov 20232:06 pmRNSForm 8.3 - Impellam Group Plc
21st Nov 202310:46 amRNSForm 8.5 (EPT/RI)
21st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
16th Nov 202311:46 amRNSForm 8.3 - Impellam Group PLC
16th Nov 202311:24 amRNSForm 8.5 (EPT/RI)
16th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Nov 20231:33 pmRNSForm 8.3 - Impellam Group Plc
15th Nov 20239:29 amRNSForm 8.5 (EPT/RI)
15th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Nov 202312:36 pmRNSForm 8.3 - Impellam Group Plc
14th Nov 202310:34 amRNSForm 8.5 (EPT/RI)
14th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
13th Nov 202311:51 amRNSForm 8.3 - Impellam Group Plc
13th Nov 202311:39 amRNSForm 8.5 (EPT/RI)
13th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th Nov 202312:16 pmRNSForm 8.3 - Impellam Group Plc
10th Nov 202310:37 amRNSForm 8.5 (EPT/RI)
10th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Nov 202311:45 amRNSForm 8.3 - Impellam Group PLC
8th Nov 20235:46 pmRNSPUSU Extension and Interim Dividend
8th Nov 20234:07 pmRNSExtension of PUSU Deadline
8th Nov 20232:04 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202312:29 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202311:02 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Nov 202310:45 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 202311:18 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 20239:22 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSTransaction in Own Shares & Rule 2.9 Announcement
2nd Nov 202312:09 pmRNSForm 8.3 - Impellam Group PLC
2nd Nov 20239:57 amRNSForm 8.5 (EPT/RI)
2nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20232:21 pmRNSForm 8.3 - Impellam Group PLC
1st Nov 202310:30 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:30 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Oct 202311:28 amRNSForm 8.3 - Impellam Group PLC
30th Oct 202312:35 pmRNSForm 8.3 - Impellam Group PLC
26th Oct 202310:45 amRNSForm 8.5 (EPT/RI)
26th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
25th Oct 20233:41 pmRNSExtension of PUSU Deadline
25th Oct 202311:47 amRNSForm 8.5 (EPT/RI)
25th Oct 202311:17 amRNSForm 8.3 - Impellam Group plc
25th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Oct 202311:07 amRNSForm 8.5 (EPT/RI)
24th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Oct 202311:13 amRNSForm 8.5 (EPT/RI)
17th Oct 202311:38 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.